Trials / Completed
CompletedNCT01090596
Changes in mRNA Expression Following Exposure to Naproxen
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Research Associates of New York, LLP · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Using tissue samples obtained from a previous study, the effect of naproxen on the gene expression profiles of antral mucosal tissue will be assessed. We hypothesize that there will be distinct changes in the gene expression profiles of samples taken from individuals treated with naproxen versus samples taken from individuals treated with placebo.
Detailed description
We will use microarray technology to quantify the transcriptome-wide changes in gene expression in said-samples.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Naproxen | 500mg naproxen, twice daily for 7 days |
| DRUG | Placebo | 1 tab,twice a day for a seven days |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2008-06-01
- Completion
- 2008-07-01
- First posted
- 2010-03-22
- Last updated
- 2010-03-22
Source: ClinicalTrials.gov record NCT01090596. Inclusion in this directory is not an endorsement.